[![Travis CI Build
Status](https://travis-ci.org/erblast/fda_inspections.svg?branch=master)](https://travis-ci.org/erblast/fda_inspections)


<style>
  .main-container {
    max-width: 1920px !important;
  }
</style>

## Background

We set-up an interactive dashboard to derive insights from the FDA Clinical Inspections database. This dashboard is open access and meant to be used by clinical quality professionals.  

Authors: Timothé Ménard, Björn Koneswarakantha

Corresponding Research Letter currently under review

Related work  
https://rd.springer.com/article/10.1007/s40264-019-00831-4  
https://rd.springer.com/article/10.1007%2Fs40264-019-00894-3  

## Dashboard

- Cut-off date 02-Dec-2019. Data pulled [from CLIIL database](https://www.accessdata.fda.gov/scripts/cder/CLIIL/index.cfm) on 12-Dec-2019

- DA, Data Audit: An inspection in which the focus is on verification of study data.

- FC,  For Cause: An inspection in which the focus is on the conduct of the study by the Clinical Investigator

[direct link](https://public.tableau.com/views/dashboard_15762479003310/Dashboard2?:embed=y&:display_count=n&:origin=viz_share_link)


<iframe src="https://public.tableau.com/views/dashboard_15762479003310/Dashboard2?:display_count=y&:origin=viz_share_link?:embed=yes&:display_count=yes&:showVizHome=no" width = '1280' height = '900'></iframe>

